Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome (original) (raw)

Nature volume 499, pages 97–101 (2013)Cite this article

Subjects

A Corrigendum to this article was published on 29 January 2014

Abstract

Obesity has become more prevalent in most developed countries over the past few decades, and is increasingly recognized as a major risk factor for several common types of cancer1. As the worldwide obesity epidemic has shown no signs of abating2, better understanding of the mechanisms underlying obesity-associated cancer is urgently needed. Although several events were proposed to be involved in obesity-associated cancer1,3, the exact molecular mechanisms that integrate these events have remained largely unclear. Here we show that senescence-associated secretory phenotype (SASP)4,5 has crucial roles in promoting obesity-associated hepatocellular carcinoma (HCC) development in mice. Dietary or genetic obesity induces alterations of gut microbiota, thereby increasing the levels of deoxycholic acid (DCA), a gut bacterial metabolite known to cause DNA damage6. The enterohepatic circulation of DCA provokes SASP phenotype in hepatic stellate cells (HSCs)7, which in turn secretes various inflammatory and tumour-promoting factors in the liver, thus facilitating HCC development in mice after exposure to chemical carcinogen. Notably, blocking DCA production or reducing gut bacteria efficiently prevents HCC development in obese mice. Similar results were also observed in mice lacking an SASP inducer8 or depleted of senescent HSCs, indicating that the DCA–SASP axis in HSCs has key roles in obesity-associated HCC development. Moreover, signs of SASP were also observed in the HSCs in the area of HCC arising in patients with non-alcoholic steatohepatitis3, indicating that a similar pathway may contribute to at least certain aspects of obesity-associated HCC development in humans as well. These findings provide valuable new insights into the development of obesity-associated cancer and open up new possibilities for its control.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Accession codes

Accessions

DDBJ/GenBank/EMBL

Data deposits

Bacterial 16S rRNA amplicon sequence data have been deposited in DDBJ (http://www.ddbj.nig.ac.jp/index-e.html) with the accession number DRA000952.

References

  1. Khandekar, M. J., Cohen, P. & Spiegelman, B. M. Molecular mechanisms of cancer development in obesity. Nature Rev. Cancer 11, 886–895 (2011)
    Article CAS Google Scholar
  2. Calle, E. E. & Kaaks, R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nature Rev. Cancer 4, 579–591 (2004)
    Article CAS Google Scholar
  3. Sun, B. & Karin, M. Obesity, inflammation, and liver cancer. J. Hepatol. 56, 704–713 (2012)
    Article CAS Google Scholar
  4. Coppé, J. P. et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6, 2853–2868 (2008)
    Article Google Scholar
  5. Kuilman, T. & Peeper, D. S. Senescence-messaging secretome: SMS-ing cellular stress. Nature Rev. Cancer 9, 81–94 (2009)
    Article CAS Google Scholar
  6. Ridlon, J. M., Kang, D. J. & Hylemon, P. B. Bile salt biotransformations by human intestinal bacteria. J. Lipid Res. 47, 241–259 (2006)
    Article CAS Google Scholar
  7. Friedman, S. L. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 88, 125–172 (2008)
    Article CAS Google Scholar
  8. Orjalo, A. V., Bhaumik, D., Gengler, B. K., Scott, G. K. & Campisi, J. Cell surface-bound IL-1α is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc. Natl Acad. Sci. USA 106, 17031–17036 (2009)
    Article ADS CAS Google Scholar
  9. Collado, M. & Serrano, M. Senescence in tumours: evidence from mice and humans. Nature Rev. Cancer 10, 51–57 (2010)
    Article CAS Google Scholar
  10. Kuilman, T., Michaloglou, C., Mooi, W. J. & Peeper, D. S. The essence of senescence. Genes Dev. 24, 2463–2479 (2010)
    Article CAS Google Scholar
  11. Krizhanovsky, V. et al. Senescence of activated stellate cells limits liver fibrosis. Cell 134, 657–667 (2008)
    Article CAS Google Scholar
  12. Kang, T. W. et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479, 547–551 (2011)
    Article ADS CAS Google Scholar
  13. Park, E. J. et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140, 197–208 (2010)
    Article CAS Google Scholar
  14. Newell, P. et al. Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo. J. Hepatol. 51, 725–733 (2009)
    Article CAS Google Scholar
  15. Serrano, M. et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27–37 (1996)
    Article CAS Google Scholar
  16. Ohtani, N. et al. Visualizing the dynamics of p21Waf1/Cip1 cyclin-dependent kinase inhibitor expression in living animals. Proc. Natl Acad. Sci. USA 104, 15034–15039 (2007)
    Article ADS CAS Google Scholar
  17. Coppé, J.-P. et al. Tumor suppressor and aging biomarker p16INK4a induces cellular senescence without the associated inflammatory secretory phenotype. J. Biol. Chem. 286, 36396–36403 (2011)
    Article Google Scholar
  18. Sato, Y. et al. Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nature Biotechnol. 26, 431–442 (2008)
    Article CAS Google Scholar
  19. Ley, R. E., Turnbaugh, P. J., Klein, S. & Gordon, J. I. Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022–1023 (2006)
    Article ADS CAS Google Scholar
  20. Dapito, D. H. et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 21, 504–516 (2012)
    Article CAS Google Scholar
  21. Payne, C. M. et al. Deoxycholate induces mitochondrial oxidative stress and activates NF-κB through multiple mechanisms in HCT-116 colon epithelial cells. Carcinogenesis 28, 215–222 (2007)
    Article CAS Google Scholar
  22. Takahashi, A. et al. DNA damage signaling triggers degradation of histone methyltransferases through APC/CCdh1 in senescent cells. Mol. Cell 45, 123–131 (2012)
    Article CAS Google Scholar
  23. McGarr, S. E., Ridlon, J. M. & Hylemon, P. B. Diet, anaerobic bacterial metabolism, and colon cancer: a review of the literature. J. Clin. Gastroenterol. 39, 98–109 (2005)
    PubMed Google Scholar
  24. Kitazawa, S. et al. Enhanced preneoplastic liver lesion development under ‘selection pressure’ conditions after administration of deoxycholic or lithocholic acid in the initiation phase in rats. Carcinogenesis 11, 1323–1328 (1990)
    Article CAS Google Scholar
  25. Minamida, K., Ohashi, M., Hara, H., Asano, K. & Tomita, F. Effects of ingestion of difructose anhydride III (DFA III) and the DFA III-assimilating bacterium Ruminococcus productus on rat intestine. Biosci. Biotechnol. Biochem. 70, 332–339 (2006)
    Article CAS Google Scholar
  26. Beuers, U. Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat. Clin. Pract. Gastroenterol. Hepatol. 3, 318–328 (2006)
    Article CAS Google Scholar
  27. Ridlon, J. M. & Hylemon, P. B. Identification and characterization of two bile acid coenzyme A transferases from Clostridium scindens, a bile acid 7α-dehydroxylating intestinal bacterium. J. Lipid Res. 53, 66–76 (2012)
    Article CAS Google Scholar
  28. Schnabl, B., Purbeck, G. A., Choi, Y. H., Hagedorn, C. H. & Brenner, D. A. Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype. Hepatology 37, 653–664 (2003)
    Article CAS Google Scholar
  29. Takuma, Y. & Nouso, K. Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review. World J. Gastroenterol. 16, 1436–1441 (2010)
    Article CAS Google Scholar
  30. Rafter, J. J. et al. Cellular toxicity of fecal water depends on diet. Am. J. Clin. Nutr. 45, 559–563 (1987)
    Article CAS Google Scholar
  31. Horai, R. et al. Production of mice deficient in genes for interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 receptor antagonist shows that IL-1β is crucial in turpentine-induced fever development and glucocorticoid secretion. J. Exp. Med. 187, 1463–1475 (1998)
    Article CAS Google Scholar
  32. Reagan-Shaw, S., Nihal, M. & Ahmad, N. Dose translation from animal to human studies revisited. FASEB J. 22, 659–661 (2008)
    Article CAS Google Scholar
  33. Yamakoshi, K. et al. Real-time in vivo imaging of p16Ink4a reveals cross talk with p53. J. Cell Biol. 186, 393–407 (2009)
    Article CAS Google Scholar
  34. Collins, M. D. et al. The phylogeny of the genus Clostridium: proposal of five new general and eleven new species combinations. Int. J. Syst. Bacteriol. 44, 812–826 (1994)
    Article CAS Google Scholar
  35. Atarashi, K. et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337–341 (2011)
    Article ADS CAS Google Scholar
  36. Song, Y., Liu, C. & Finegold, S. M. Real-time PCR quantitation of clostridia in feces of autistic children. Appl. Environ. Microbiol. 70, 6459–6465 (2004)
    Article CAS Google Scholar
  37. Ooga, T. et al. Metabolomic anatomy of an animal model revealing homeostatic imbalances in dyslipidaemia. Mol. Biosyst. 7, 1217–1223 (2011)
    Article CAS Google Scholar
  38. Muto, A. et al. Detection of Δ4-3-oxo-steroid 5β-reductase deficiency by LC–ESI-MS/MS measurement of urinary bile acids. J. Chromatogr. B 900, 24–31 (2012)
    Article CAS Google Scholar
  39. Sekiya, Y. et al. Down-regulation of cyclin E1 expression by microRNA-195 accounts for interferon-β-induced inhibition of hepatic stellate cell proliferation. J. Cell. Physiol. 226, 2535–2542 (2011)
    Article CAS Google Scholar

Download references

Acknowledgements

The authors thank M. Oshima for suggestions in antibiotics treatment and members of the Hara laboratory for discussion during the preparation of this manuscript. This work was supported by grants from Japan Science and Technology Agency (JST), Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), Ministry of Health, Labour and Welfare of Japan (MHLW), Uehara Memorial Foundation and Takeda Science Foundation. S.Y. was partly supported by a postdoctoral fellowship from the Japan Society for Promotion of Science (JSPS). T.M.L. was partly supported by an international scholarship from the Ajinomoto Scholarship Foundation.

Author information

Author notes

  1. Shin Yoshimoto and Naoko Ohtani: These authors contributed equally to this work.

Authors and Affiliations

  1. Division of Cancer Biology, Cancer Institute, Japanese Foundation for Cancer Research, Koto-ku, Tokyo 135-8550, Japan,
    Shin Yoshimoto, Tze Mun Loo, Seidai Sato, Eiji Hara & Naoko Ohtani
  2. CREST, Japan Science and Technology Agency, Kawaguchi, Saitama 332-0012, Japan,
    Shin Yoshimoto, Tze Mun Loo, Seidai Sato, Kenya Honda & Eiji Hara
  3. Department of Applied Biological Science, Tokyo University of Science, Noda, Chiba 278-8510, Japan,
    Tze Mun Loo
  4. Research Center for Allergy and Immunology, RIKEN, Yokohama, Kanagawa 230-0045, Japan,
    Koji Atarashi & Kenya Honda
  5. PRESTO, Japan Science and Technology Agency, Kawaguchi, Saitama 332-0012, Japan,
    Koji Atarashi & Naoko Ohtani
  6. Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Koto-ku, Tokyo 135-8550, Japan,
    Hiroaki Kanda & Yuichi Ishikawa
  7. Institute for Genome Research, University of Tokushima, Tokushima 770-8503, Japan,
    Seiichi Oyadomari
  8. Research Institute for Biological Science, Tokyo University of Science, Noda, Chiba 278-8510, Japan,
    Yoichiro Iwakura
  9. Graduate School of Frontier Sciences, University of Tokyo, Kashiwa, Chiba 277-8561, Japan,
    Kenshiro Oshima & Masahira Hattori
  10. School of Veterinary Medicine, Azabu University, Sagamihara, Kanagawa 229-8501, Japan,
    Hidetoshi Morita

Authors

  1. Shin Yoshimoto
  2. Tze Mun Loo
  3. Koji Atarashi
  4. Hiroaki Kanda
  5. Seidai Sato
  6. Seiichi Oyadomari
  7. Yoichiro Iwakura
  8. Kenshiro Oshima
  9. Hidetoshi Morita
  10. Masahira Hattori
  11. Kenya Honda
  12. Yuichi Ishikawa
  13. Eiji Hara
  14. Naoko Ohtani

Contributions

E.H. and N.O. designed the experiments, analysed the data and wrote the manuscript. N.O., S.Y. and T.M.L. performed obesity-induced liver cancer experiments. K.A., K.O., H.M., M.H. and K.H. performed bacterial genome data analysis. H.K., S.S. and Y.I. performed histopathological analysis of mouse and human liver cancer specimens. S.O. performed metabolite analysis. Y.I. provided Il-1β −/− mice. E.H. oversaw the projects.

Corresponding author

Correspondence toEiji Hara.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Figures

This file contains Supplementary Figures 1-16 and Supplementary References. (PDF 17390 kb)

PowerPoint slides

Rights and permissions

About this article

Cite this article

Yoshimoto, S., Loo, T., Atarashi, K. et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome.Nature 499, 97–101 (2013). https://doi.org/10.1038/nature12347

Download citation

This article is cited by

Editorial Summary

Epidemiological data have demonstrated a link between obesity and cancer. This study shows that in a mouse model of liver cancer, a high-fat diet strongly enhances tumorigenesis by provoking a senescence-associated secretory phenotype (SASP), a recently identified senescent phenotype associated with the secretion of various tumour-promoting factors. Antibiotic and other interventions show that the fatty diet altered the composition of intestinal bacteria leading to more production of deoxycholic acid (DCA), a by-product of microbial bile acid metabolism that is known to cause DNA damage. The authors suggest that DCA, acting with other as-yet unknown factors, induces senescence and the secretion of various senescence-associated cytokines in hepatic stellate cells. These cytokines in turn act to promote the development of liver cancer. These findings highlight the complex mechanistic links between diet, the microbiota and cancer and suggest novel therapeutic approaches.

Associated content

Nature News & Views 26 Jun 2013